Advanced Cervical Cancer Survival Improvement with Bevacizumab

被引：0
|
作者：
Klaiber-Hakimi, M. [1 ]
机构：
[1] Univ Leipzig, Univ Krebszentrum Leipzig UCCL, D-04103 Leipzig, Germany
来源：
ONKOLOGE | 2015年 / 21卷 / 01期
关键词：
D O I：
10.1007/s00761-014-2842-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [21] A case of nasal septal perforation caused by bevacizumab for advanced cervical cancer
    Taira, Yusuke
    Shimoji, Yuko
    Nakasone, Tadaharu
    Arakaki, Yoshihisa
    Nakamoto, Tomoko
    Kudaka, Wataru
    Aoki, Yoichi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (02) : 833 - 837
  • [22] BEVACIZUMAB FOR RECURRENT, PERSISTENT OR ADVANCED CERVICAL CANCER: EXPERIENCE OF THREE PORTUGUESE INSTITUTIONS
    Neves, Maria Teresa
    Baptista, Carlota
    Simoes, Filipa
    Neto Silva, Diana
    Ferreira, Andre
    Simoes, Pedro
    Arede, Ana Julia
    Casa-Nova, Mafalda
    Malheiro, Mariana
    Teixeira, Jose Alberto
    Martins, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A110 - A110
  • [23] Bevacizumab for the treatment of cervical cancer
    Bizzarri, Nicolo
    Ghirardi, Valentina
    Alessandri, Franco
    Venturini, Pier Luigi
    Menada, Mario Valenzano
    Rundle, Stuart
    Maggiore, Umberto Leone Roberti
    Ferrero, Simone
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 407 - 419
  • [24] Improving Survival with Topotecan, Paclitaxel, and Bevacizumab for Recurrent Small Cell Cervical Cancer
    Frumovitz, M.
    Munsell, M.
    Byers, L.
    Ramalingam, P.
    Brown, J.
    Coleman, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 526 - 527
  • [25] Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis
    Tao, Wanjun
    Yang, Jia
    Jiang, Yongxian
    Chen, Wenwen
    Wang, Yixin
    DOSE-RESPONSE, 2020, 18 (03):
  • [26] Painful cervical esophageal erosion in a patient with advanced colorectal cancer treated with bevacizumab
    Carlos Eduardo Paiva
    Yara Cristina de Paiva Maia
    Bianca Sakamoto Ribeiro Paiva
    Mauro Masson Lerco
    Investigational New Drugs, 2010, 28 : 882 - 883
  • [27] Painful cervical esophageal erosion in a patient with advanced colorectal cancer treated with bevacizumab
    Paiva, Carlos Eduardo
    de Paiva Maia, Yara Cristina
    Ribeiro Paiva, Bianca Sakamoto
    Lerco, Mauro Masson
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 882 - 883
  • [28] Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
    Friedman, Claire F.
    Charen, Alexandra Snyder
    Zhou, Qin
    Carducci, Michael A.
    De Meritens, Alexandre Buckley
    Corr, Bradley R.
    Fu, Siqing
    Hollmann, Travis J.
    Iasonos, Alexia
    Konner, Jason A.
    Konstantinopoulos, Panagiotis A.
    Modesitt, Susan C.
    Sharon, Elad
    Aghajanian, Carol
    Zamarin, Dmitriy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [29] Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer
    Suzuki, Kazuhiro
    Nagao, Shoji
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 554 - 557
  • [30] Neoadjuvant adebrelimab plus bevacizumab in locally advanced cervical cancer: an exploratory trial
    Pei, Xuan
    Liu, Shuai
    Wang, Jun
    Fu, Yi
    Jiang, Wei
    Zhou, Lin
    Shen, Wenbin
    Ye, Shuang
    Sun, Min
    Shan, Boer
    Yang, Huijuan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A137 - A138
12345